Karikalan Nagarajan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karikalan Nagarajan has a total of 146 co-authors. Here are the top co-authors by number of shared publications:
- Malaisamy Muniyandi
Affiliation ICMR-National Institute for Research in Tuberculosis, Chennai, India
5 shared publications Malaisamy Muniyandi
ICMR-National Institute for Research in Tuberculosis (NIRT), Chennai, Tamil Nadu, 600031, India
4 shared publicationsAsha Frederick
Medical & Rural Health Services (TM) & State TB Office, National Tuberculosis Elimination Programme , Chennai 600006 , Tamil Nadu
3 shared publicationsBharathidasan Palani
Department of Health Economics, ICMR–National Institute for Research in Tuberculosis, Chennai, India
3 shared publications- Chandrasekaran Padmapriyadarsini
ICMR-National Institute for Research in Tuberculosis, Chennai 600031, India
3 shared publications Prathiksha Giridharan
Division of Infectious Disease Epidemiology, Indian Council of Medical Research- National Institute of Epidemiology , Chennai 600077
3 shared publications
Latest Publications
- Open Access
- 18 March 2026
- Published by Oxford University Press (OUP) in International Health
- Vol. 18 (6) , 801-809
Implementation challenges of 3-month once-weekly rifapentine and isoniazid TB-preventive treatment in India
Background: Implementing three months of once-weekly rifapentine and isoniazid (3HP) for tuberculosis preventive therapy among household contacts (HHCs) of bacteriologically confirmed pulmonary TB patients in India presents programmatic challenges requiring understanding from beneficiary and provider perspectives. Methods: From May 2023 to March 2024, nine focus group discussions were conducted across five rural and urban program settings: three with HHCs who received 3HP (n=28) and six with frontline healthcare providers (n=69) delivering the regimen within a multicentric implementation study. Descriptive thematic analysis explored experiences, perceptions, and implementation challenges. Results: Analysis of FGDs yielded four major themes: (i) perceptions and acceptance of 3HP; (ii) barriers to 3HP; (iii) advocacy and communication and social mobilization; and (iv) suggestions for improving 3HP. Participants appreciated the short, once-weekly regimen and family encouragement supporting adherence. However, reluctance to undergo testing without symptoms, fear of side effects, stigma, and access barriers limited uptake. Suggested solutions included transport support, mobile X-ray services, reminder tools, and family DOTS providers. Providers highlighted workforce shortages and the need for additional staff. Conclusion: Both groups emphasized tailored counselling, strengthened community awareness, and media advocacy to improve uptake, adherence, and program sustainability of 3HP implementation at scale nationwide.
- 18 March 2026
- Published by Oxford University Press (OUP) in International Health
- Vol. 18 (6) , 801-809
Open AccessImplementation challenges of 3-month once-weekly rifapentine and isoniazid TB-preventive treatment in India
Background: Implementing three months of once-weekly rifapentine and isoniazid (3HP) for tuberculosis preventive therapy among household contacts (HHCs) of bacteriologically confirmed pulmonary TB patients in India presents programmatic challenges requiring understanding from beneficiary and provider perspectives. Methods: From May 2023 to March 2024, nine focus group discussions were conducted across five rural and urban program settings: three with HHCs who received 3HP (n=28) and six with frontline healthcare providers (n=69) delivering the regimen within a multicentric implementation study. Descriptive thematic analysis explored experiences, perceptions, and implementation challenges. Results: Analysis of FGDs yielded four major themes: (i) perceptions and acceptance of 3HP; (ii) barriers to 3HP; (iii) advocacy and communication and social mobilization; and (iv) suggestions for improving 3HP. Participants appreciated the short, once-weekly regimen and family encouragement supporting adherence. However, reluctance to undergo testing without symptoms, fear of side effects, stigma, and access barriers limited uptake. Suggested solutions included transport support, mobile X-ray services, reminder tools, and family DOTS providers. Providers highlighted workforce shortages and the need for additional staff. Conclusion: Both groups emphasized tailored counselling, strengthened community awareness, and media advocacy to improve uptake, adherence, and program sustainability of 3HP implementation at scale nationwide.
- Open Access
- 13 February 2026
- Published by Frontiers Media SA in Frontiers in Tuberculosis
- Vol. 4, 1713844
An integrated psycho-social intervention to improve self-efficacy toward TB treatment uptake and infection prevention among patients and family caregivers: a multicentric implementation research study protocol
Background: The individuals with tuberculosis (TB) experience a variety of barriers, needs, and challenges when receiving the treatment. Evidence on holistic patient-centered psychosocial interventions that promote self-efficacy and the ability to complete treatment-related tasks and goals is scarce in India. Objectives: To adapt an intervention aimed at strengthening the self-efficacy of individuals on TB treatment and their family caregivers, and to evaluate its effectiveness compared with the standard of care on the primary outcome of improved TB treatment self-efficacy and secondary outcomes of improved medication adherence, reduced TB-related stigma, and improved infection control practices. Methods: A multicentric hybrid Type I mixed method implementation research design will be used to adapt and evaluate the implementation feasibility and effectiveness of delivering a self-efficacy-based intervention under National Tuberculosis Elimination Program (NTEP) settings in India. A two-arm non-randomized cluster intervention design will be employed to evaluate the impact of a self-efficacy intervention, which includes individual counseling and peer group sessions ( n = 240) in comparison to the standard of care ( n = 240) on primary and secondary outcomes. Qualitative in-depth interviews and focus group discussions, guided by the Consolidated Framework for Implementation Research (CFIR), will be conducted to explore contextual factors influencing implementation. Discussion: The proposed study could generate evidence for a holistic and evidence-informed psycho-social intervention for individuals with TB and their family caregivers. It aims to improve their self-efficacy in overcoming TB treatment challenges and address the key psycho-social barriers comprehensively. Qualitative insights from the study are expected to guide/facilitate the pragmatic scale-up of self-efficacy-based interventions under the National TB program of India. Clinical trial registration: The study has been registered in the Clinical Trial Registry of India CTRI/2024/05/066847.
- 13 February 2026
- Published by Frontiers Media SA in Frontiers in Tuberculosis
- Vol. 4, 1713844
Open AccessAn integrated psycho-social intervention to improve self-efficacy toward TB treatment uptake and infection prevention among patients and family caregivers: a multicentric implementation research study protocol
Background: The individuals with tuberculosis (TB) experience a variety of barriers, needs, and challenges when receiving the treatment. Evidence on holistic patient-centered psychosocial interventions that promote self-efficacy and the ability to complete treatment-related tasks and goals is scarce in India. Objectives: To adapt an intervention aimed at strengthening the self-efficacy of individuals on TB treatment and their family caregivers, and to evaluate its effectiveness compared with the standard of care on the primary outcome of improved TB treatment self-efficacy and secondary outcomes of improved medication adherence, reduced TB-related stigma, and improved infection control practices. Methods: A multicentric hybrid Type I mixed method implementation research design will be used to adapt and evaluate the implementation feasibility and effectiveness of delivering a self-efficacy-based intervention under National Tuberculosis Elimination Program (NTEP) settings in India. A two-arm non-randomized cluster intervention design will be employed to evaluate the impact of a self-efficacy intervention, which includes individual counseling and peer group sessions ( n = 240) in comparison to the standard of care ( n = 240) on primary and secondary outcomes. Qualitative in-depth interviews and focus group discussions, guided by the Consolidated Framework for Implementation Research (CFIR), will be conducted to explore contextual factors influencing implementation. Discussion: The proposed study could generate evidence for a holistic and evidence-informed psycho-social intervention for individuals with TB and their family caregivers. It aims to improve their self-efficacy in overcoming TB treatment challenges and address the key psycho-social barriers comprehensively. Qualitative insights from the study are expected to guide/facilitate the pragmatic scale-up of self-efficacy-based interventions under the National TB program of India. Clinical trial registration: The study has been registered in the Clinical Trial Registry of India CTRI/2024/05/066847.
- Open Access
Predictors of healthcare seeking for tuberculosis symptoms in the private healthcare facilities: findings from a cross-sectional population-based survey in Tamil Nadu
Objectives: To identify the factors influencing the choice of private healthcare facilities among individuals experiencing tuberculosis (TB) symptoms. Design: Cross-sectional study. Setting: The data for this study were obtained from a cross-sectional population-based TB prevalence survey conducted in 33 districts of Tamil Nadu, a state in southern India, between February 2021 to July 2022. Participants: 130 932 individuals, 15 years and above, residents of the selected cluster for the past 1 month, were included. Hospitalised patients, sick/morbid individuals and the institutional population were excluded. Results: Of 143 005 eligible individuals, 130 932 (91.6%) participated. Among them, 9540 individuals were found to have at least one TB symptom. Of these symptomatic individuals, 2678 sought healthcare, with 62.7% in the public facilities and 37.3% in private facilities. Factors associated with seeking care in the private healthcare facilities included working in organised sector (aOR: 1.3; 95% CI 1.0 to 1.7; p<0.05), being a housewife (aOR: 1.3; 95% CI 1.0 to 1.7; p<0.05), having symptom of expectoration (aOR: 1.3; 95% CI 1.1 to 1.6; p<0.05) and fatigue (aOR: 1.5; 95% CI 1.2 to 1.9; p<0.05). Conversely, individual with symptom of weight loss (aOR: 0.4; 95% CI 00.3 to 00.6; p<0.05), loss of appetite (aOR: 0.8; 95% CI 0.6 to 0.9; p<0.05), chest pain (aOR: 0.6; 95% CI 0.5 to 0.7; p<0.05), history of past TB care (aOR: 0.4; 95% CI 0.3 to 0.5; p25 years (aOR: 0.6; 95% CI 0.4 to 0.9; p<0.05), living in a rural area (aOR: 0.7; 95% CI 0.6 to 0.8; p<0.05) and living below the poverty line (aOR: 0.7; 95% CI 0.6 to 0.9; p<0.05) were less likely to seek care in the private healthcare facilities. Conclusion: The study highlights the distinct factors that could affect healthcare seeking for TB symptoms in the public and private healthcare settings for TB and the need for tailored interventions and customised healthcare policies to address such gaps and distinctions in care seeking.
Open AccessPredictors of healthcare seeking for tuberculosis symptoms in the private healthcare facilities: findings from a cross-sectional population-based survey in Tamil Nadu
Objectives: To identify the factors influencing the choice of private healthcare facilities among individuals experiencing tuberculosis (TB) symptoms. Design: Cross-sectional study. Setting: The data for this study were obtained from a cross-sectional population-based TB prevalence survey conducted in 33 districts of Tamil Nadu, a state in southern India, between February 2021 to July 2022. Participants: 130 932 individuals, 15 years and above, residents of the selected cluster for the past 1 month, were included. Hospitalised patients, sick/morbid individuals and the institutional population were excluded. Results: Of 143 005 eligible individuals, 130 932 (91.6%) participated. Among them, 9540 individuals were found to have at least one TB symptom. Of these symptomatic individuals, 2678 sought healthcare, with 62.7% in the public facilities and 37.3% in private facilities. Factors associated with seeking care in the private healthcare facilities included working in organised sector (aOR: 1.3; 95% CI 1.0 to 1.7; p<0.05), being a housewife (aOR: 1.3; 95% CI 1.0 to 1.7; p<0.05), having symptom of expectoration (aOR: 1.3; 95% CI 1.1 to 1.6; p<0.05) and fatigue (aOR: 1.5; 95% CI 1.2 to 1.9; p<0.05). Conversely, individual with symptom of weight loss (aOR: 0.4; 95% CI 00.3 to 00.6; p<0.05), loss of appetite (aOR: 0.8; 95% CI 0.6 to 0.9; p<0.05), chest pain (aOR: 0.6; 95% CI 0.5 to 0.7; p<0.05), history of past TB care (aOR: 0.4; 95% CI 0.3 to 0.5; p25 years (aOR: 0.6; 95% CI 0.4 to 0.9; p<0.05), living in a rural area (aOR: 0.7; 95% CI 0.6 to 0.8; p<0.05) and living below the poverty line (aOR: 0.7; 95% CI 0.6 to 0.9; p<0.05) were less likely to seek care in the private healthcare facilities. Conclusion: The study highlights the distinct factors that could affect healthcare seeking for TB symptoms in the public and private healthcare settings for TB and the need for tailored interventions and customised healthcare policies to address such gaps and distinctions in care seeking.
- Open Access
- 30 August 2025
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 10 (9) , 248
Alcohol Consumption of Male Tuberculosis Index Cases and Tuberculosis Transmission Among Social Contacts in Puducherry, India: A Cross-Sectional Analytical Study
We aimed to compare the proportion of tuberculosis infection among social contacts of male tuberculosis Index case with and without alcohol use in the Puducherry district. A cross-sectional study using ego-centric approach was conducted between November 2023 and May 2024. A total of 713 social contacts of 106 male pulmonary tuberculosis index cases were enrolled, stratified by alcohol-use (AUDIT ≥ 8): 358 contacts from 45 alcohol-using cases and 355 from 61 non-alcohol-use cases. Social contacts were defined based on the frequency and duration of shared indoor exposure with index cases within the past three months. Tuberculosis infection was screened with Cy-Tb skin test (≥5 mm induration) at the third month of index case treatment. Univariate and multivariable analysis were conducted to identify factors associated with tuberculosis transmission. Among the 358 social contacts of alcohol-use index cases, 33.8% (n = 121; 95% CI, 29.1–38.8%) tested positive for tuberculosis infection, significantly higher than 21.7% (n = 77; 95% CI, 17.7–26.3%) among 355 contacts of non-alcohol-use cases. Regression analysis revealed that contacts of alcohol-using index cases (aOR = 1.6, p < 0.05), were significantly associated with tuberculosis infection. Alcohol-use among tuberculosis patients significantly increases the risk of tuberculosis infection in their social networks.
- 30 August 2025
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 10 (9) , 248
Open AccessAlcohol Consumption of Male Tuberculosis Index Cases and Tuberculosis Transmission Among Social Contacts in Puducherry, India: A Cross-Sectional Analytical Study
We aimed to compare the proportion of tuberculosis infection among social contacts of male tuberculosis Index case with and without alcohol use in the Puducherry district. A cross-sectional study using ego-centric approach was conducted between November 2023 and May 2024. A total of 713 social contacts of 106 male pulmonary tuberculosis index cases were enrolled, stratified by alcohol-use (AUDIT ≥ 8): 358 contacts from 45 alcohol-using cases and 355 from 61 non-alcohol-use cases. Social contacts were defined based on the frequency and duration of shared indoor exposure with index cases within the past three months. Tuberculosis infection was screened with Cy-Tb skin test (≥5 mm induration) at the third month of index case treatment. Univariate and multivariable analysis were conducted to identify factors associated with tuberculosis transmission. Among the 358 social contacts of alcohol-use index cases, 33.8% (n = 121; 95% CI, 29.1–38.8%) tested positive for tuberculosis infection, significantly higher than 21.7% (n = 77; 95% CI, 17.7–26.3%) among 355 contacts of non-alcohol-use cases. Regression analysis revealed that contacts of alcohol-using index cases (aOR = 1.6, p < 0.05), were significantly associated with tuberculosis infection. Alcohol-use among tuberculosis patients significantly increases the risk of tuberculosis infection in their social networks.
- Open Access
- 21 July 2025
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (8) , ofaf433
Economic Burden of TB Deaths in India (2021): A Retrospective Cross-sectional Study
Background: India accounts for 26% of global tuberculosis (TB) deaths. Evidence of economic losses due to TB deaths can influence policy decisions and optimising resource allocations. In this study, we estimated the economic burden of TB deaths in terms of GDP across Indian states, regions and different demographic groups. Methodology: In this modelling study, using Human Capital Approach (HCA), we estimated the non-health GDP losses due to TB deaths in India for 2021 at sub-national level. The total monetary value for the years of life lost (TMVYLL) due to TB deaths was calculated. To check the uncertainty in the economic losses, sensitivity analysis was conducted using different discount rates of 3%, 5% and 10%. Results: In 2021, 0.393 million TB deaths occurred in India, which would reduce the non-health GDP by US$9.1 billion. Nearly 33.5%, 25.6%, 18.5% and 9.3% of that economic loss would come from North, West, South and North East states of India respectively. On an average, each TB death resulted in non-health GDP loss of US$23161. The economic burden was highest among younger males (20.5%) followed by males aged >75 years (17.3%). The economic cost was minimal among adolescents and young males accounting only for 3.4%. Conclusion: Our HCA driven estimates underscore a high economic burden of TB in the Northern and Western Zones of India, particularly among youth and males. These findings underscore the urgent need for concerted multi-sectoral efforts, sustained investments and strategies to reduce TB deaths and mitigate the resulting economic losses.
- 21 July 2025
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (8) , ofaf433
Open AccessEconomic Burden of TB Deaths in India (2021): A Retrospective Cross-sectional Study
Background: India accounts for 26% of global tuberculosis (TB) deaths. Evidence of economic losses due to TB deaths can influence policy decisions and optimising resource allocations. In this study, we estimated the economic burden of TB deaths in terms of GDP across Indian states, regions and different demographic groups. Methodology: In this modelling study, using Human Capital Approach (HCA), we estimated the non-health GDP losses due to TB deaths in India for 2021 at sub-national level. The total monetary value for the years of life lost (TMVYLL) due to TB deaths was calculated. To check the uncertainty in the economic losses, sensitivity analysis was conducted using different discount rates of 3%, 5% and 10%. Results: In 2021, 0.393 million TB deaths occurred in India, which would reduce the non-health GDP by US$9.1 billion. Nearly 33.5%, 25.6%, 18.5% and 9.3% of that economic loss would come from North, West, South and North East states of India respectively. On an average, each TB death resulted in non-health GDP loss of US$23161. The economic burden was highest among younger males (20.5%) followed by males aged >75 years (17.3%). The economic cost was minimal among adolescents and young males accounting only for 3.4%. Conclusion: Our HCA driven estimates underscore a high economic burden of TB in the Northern and Western Zones of India, particularly among youth and males. These findings underscore the urgent need for concerted multi-sectoral efforts, sustained investments and strategies to reduce TB deaths and mitigate the resulting economic losses.
- Open Access
- 1 July 2025
- Published by MDPI AG in Preprints.org
Alcohol Consumption of Male Tuberculosis Index Cases and Tuberculosis Transmission Among Social Contacts in Puducherry, India: A Cross-Sectional Analytical Study
We aimed to compare the proportion of tuberculosis infection among social contacts of male tuberculosis Index case with and without alcohol use in the Puducherry district. A cross-sectional study using ego-centric approach was conducted between November 2023 and May 2024. A total of 713 social contacts of 106 male pulmonary tuberculosis index cases were enrolled, stratified by alcohol-use (AUDIT ≥8): 358 contacts from 45 alcohol-using cases and 355 from 61 non-alcohol-use cases. Social contacts were defined based on the frequency and duration of shared indoor exposure with index cases within the past three months. Tuberculosis infection was screened with Cy-Tb skin test (≥5 mm induration) at the third month of index case treatment. Univariate and multivariable analysis were conducted to identify factors associated with tuberculosis transmission. Among the 358 social contacts of alcohol-use index cases,33.8% (n=121; 95% CI, 29.1%–38.8%) tested positive for tuberculosis infection, significantly higher than 21.7% (n=77; 95% CI, 17.7%–26.3%) among 355 contacts of non-alcohol-use cases. Regression analysis revealed that contacts of alcohol-using index cases (aOR=1.6, p< 0.05), were significantly associated with tuberculosis infection. Alcohol-use among tuberculosis patients significantly increases the risk of tuberculosis infection in their social networks.
- 1 July 2025
- Published by MDPI AG in Preprints.org
Open AccessAlcohol Consumption of Male Tuberculosis Index Cases and Tuberculosis Transmission Among Social Contacts in Puducherry, India: A Cross-Sectional Analytical Study
We aimed to compare the proportion of tuberculosis infection among social contacts of male tuberculosis Index case with and without alcohol use in the Puducherry district. A cross-sectional study using ego-centric approach was conducted between November 2023 and May 2024. A total of 713 social contacts of 106 male pulmonary tuberculosis index cases were enrolled, stratified by alcohol-use (AUDIT ≥8): 358 contacts from 45 alcohol-using cases and 355 from 61 non-alcohol-use cases. Social contacts were defined based on the frequency and duration of shared indoor exposure with index cases within the past three months. Tuberculosis infection was screened with Cy-Tb skin test (≥5 mm induration) at the third month of index case treatment. Univariate and multivariable analysis were conducted to identify factors associated with tuberculosis transmission. Among the 358 social contacts of alcohol-use index cases,33.8% (n=121; 95% CI, 29.1%–38.8%) tested positive for tuberculosis infection, significantly higher than 21.7% (n=77; 95% CI, 17.7%–26.3%) among 355 contacts of non-alcohol-use cases. Regression analysis revealed that contacts of alcohol-using index cases (aOR=1.6, p< 0.05), were significantly associated with tuberculosis infection. Alcohol-use among tuberculosis patients significantly increases the risk of tuberculosis infection in their social networks.
- Open Access
- 21 April 2025
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 10 (4) , 114
Qualitative Study of Nutritional Support-Related Perceptions and Preferences Among Persons Affected by TB, Family Caregivers, and Healthcare Providers in India
Evidence on the implementation aspects of nutritional support interventions for persons with TB in India is limited. This qualitative study employed focus group discussions with persons with TB (n = 71), their family caregivers (n = 17), and healthcare providers (n = 18). The study was conducted from August 2023 to April 2024 in five states in India. Participants’ knowledge, perceptions, and practices about nutritional intake, experiences, and expectations when accessing nutritional support were explored. Four nutrition-related themes emerged: (a) the experiences and perceptions of persons with tuberculosis and their caregivers, explained by their understanding of the importance of adequate nutrition and TB cures; (b) changes in food practices, explained by protein food adoption, alongside food insecurity experienced by those in poverty; (c) Direct Benefit Transfer (DBT)-related issues, explained by insufficiency and access-related gaps; and (d) preferred choices for nutrition support delivery, explained by less preference towards the involvement of intermediaries and a public distribution system alongside preference for the provision of nutrition through treatment facilities. Our findings underscore the importance of the provision of protein-rich food and an increase in financial support based on needs assessments. Mitigating the linkage and access gaps in DBT is needed. The delivery of ready-to-consume food through tuberculosis treatment facilities could be prioritized.
- 21 April 2025
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 10 (4) , 114
Open AccessQualitative Study of Nutritional Support-Related Perceptions and Preferences Among Persons Affected by TB, Family Caregivers, and Healthcare Providers in India
Evidence on the implementation aspects of nutritional support interventions for persons with TB in India is limited. This qualitative study employed focus group discussions with persons with TB (n = 71), their family caregivers (n = 17), and healthcare providers (n = 18). The study was conducted from August 2023 to April 2024 in five states in India. Participants’ knowledge, perceptions, and practices about nutritional intake, experiences, and expectations when accessing nutritional support were explored. Four nutrition-related themes emerged: (a) the experiences and perceptions of persons with tuberculosis and their caregivers, explained by their understanding of the importance of adequate nutrition and TB cures; (b) changes in food practices, explained by protein food adoption, alongside food insecurity experienced by those in poverty; (c) Direct Benefit Transfer (DBT)-related issues, explained by insufficiency and access-related gaps; and (d) preferred choices for nutrition support delivery, explained by less preference towards the involvement of intermediaries and a public distribution system alongside preference for the provision of nutrition through treatment facilities. Our findings underscore the importance of the provision of protein-rich food and an increase in financial support based on needs assessments. Mitigating the linkage and access gaps in DBT is needed. The delivery of ready-to-consume food through tuberculosis treatment facilities could be prioritized.
- Open Access
- 7 October 2024
- Published by Sechenov University in The BRICS Health Journal
- Vol. 1 (1) , 35-58
Current challenges and future development of India’s healthcare system’ towards tuberculosis free India – research evidence and programmatic initiatives
Tuberculosis (TB), the single most infectious killer deserves special attention in a focussed manner, to reduce morbidity and mortality. We describe the challenges in the four pillars of TB control: detect or diagnosis, treat, prevent, build and elaborate the success stories, listing out newer and advanced tools like artificial intelligence, whole genome sequencing, clustered regularly interspaced short palindromic repeats based technologies, one health approach and cost effectiveness strategies for an all- round reduction in TB control. Special problems posed by paediatric and extra-pulmonary TB are dealt with. Post TB lung sequalae, reverse zoonosis and behavioural modification that can influence catastrophic costs are explored. Use of molecular and genomic methods of TB detection has revolutionized TB care with increased sensitivity of diagnosis, and timely detection of drug resistance, saving many a precious lives. Undoubtedly, the need of the hour would be shortening TB treatment duration and comprehensive preventive strategies that simultaneously decrease both the incidence and prevalence of TB. The various schemes and initiatives undertaken by the Government of India including the Pradhan Mantri TB Mukt Bharat Abhiyaan – “TB free India” stand as a unique solution in the wake of eliminating TB. India has been extending its success stories to other countries as well, by creating platforms for multilateral research and multinational implementation. This manuscript gives a concise and comprehensive outlook of process involved in TB elimination, amalgamating the research evidences with the programmatic initiatives, enlisting the existing challenges, envisaging the current achievements, providing a road map for TB elimination.
- 7 October 2024
- Published by Sechenov University in The BRICS Health Journal
- Vol. 1 (1) , 35-58
Open AccessCurrent challenges and future development of India’s healthcare system’ towards tuberculosis free India – research evidence and programmatic initiatives
Tuberculosis (TB), the single most infectious killer deserves special attention in a focussed manner, to reduce morbidity and mortality. We describe the challenges in the four pillars of TB control: detect or diagnosis, treat, prevent, build and elaborate the success stories, listing out newer and advanced tools like artificial intelligence, whole genome sequencing, clustered regularly interspaced short palindromic repeats based technologies, one health approach and cost effectiveness strategies for an all- round reduction in TB control. Special problems posed by paediatric and extra-pulmonary TB are dealt with. Post TB lung sequalae, reverse zoonosis and behavioural modification that can influence catastrophic costs are explored. Use of molecular and genomic methods of TB detection has revolutionized TB care with increased sensitivity of diagnosis, and timely detection of drug resistance, saving many a precious lives. Undoubtedly, the need of the hour would be shortening TB treatment duration and comprehensive preventive strategies that simultaneously decrease both the incidence and prevalence of TB. The various schemes and initiatives undertaken by the Government of India including the Pradhan Mantri TB Mukt Bharat Abhiyaan – “TB free India” stand as a unique solution in the wake of eliminating TB. India has been extending its success stories to other countries as well, by creating platforms for multilateral research and multinational implementation. This manuscript gives a concise and comprehensive outlook of process involved in TB elimination, amalgamating the research evidences with the programmatic initiatives, enlisting the existing challenges, envisaging the current achievements, providing a road map for TB elimination.
- Open Access
- 2 August 2024
- Published by Oxford University Press (OUP) in International Health
- Vol. 17 (3) , 259-269
Evaluating the cost-effectiveness of Cy-Tb for LTBI in India: a comprehensive economic modelling analysis
Background: Latent tuberculosis infection (LTBI) remains a significant challenge, as there is no gold standard diagnostic test. Current methods used for identifying LTBI are the interferon-γ release assay (IGRA), which is based on a blood test, and the tuberculin skin test (TST), which has low sensitivity. Both these tests are inadequate, primarily because they have limitations with the low bacterial burden characteristic of LTBI. This highlights the need for the development and adoption of more specific and accurate diagnostic tests to effectively identify LTBI. Herein we estimate the cost-effectiveness of the Cy-Tb test as compared with the TST for LTBI diagnosis. Methods: An economic modelling study was conducted from a health system perspective using decision tree analysis, which is most widely used for cost-effectiveness analysis using transition probabilities. Our goal was to estimate the incremental cost and number of TB cases prevented from LTBI using the Cy-Tb diagnostic test along with TB preventive therapy (TPT). Secondary data such as demographic characteristics, treatment outcome, diagnostic test results and cost data for the TST and Cy-Tb tests were collected from the published literature. The incremental cost-effectiveness ratio was calculated for the Cy-Tb test as compared with the TST. The uncertainty in the model was evaluated using one-way sensitivity analysis and probability sensitivity analysis. Results: The study findings indicate that for diagnosing an additional LTBI case with the Cy-Tb test and to prevent a TB case by providing TPT prophylaxis, an additional cost of 18 658 Indian rupees (US${\$}$223.5) is required. The probabilistic sensitivity analysis indicated that using the Cy-Tb test for diagnosing LTBI was cost-effective as compared with TST testing. If the cost of the Cy-Tb test is reduced, it becomes a cost-saving strategy. Conclusions: The Cy-Tb test for diagnosing LTBI is cost-effective at the current price, and price negotiations could further change it into a cost-saving strategy. This finding emphasizes the need for healthcare providers and policymakers to consider implementing the Cy-Tb test to maximize economic benefits. Bulk procurements can also be considered to further reduce costs and increase savings.
- 2 August 2024
- Published by Oxford University Press (OUP) in International Health
- Vol. 17 (3) , 259-269
Open AccessEvaluating the cost-effectiveness of Cy-Tb for LTBI in India: a comprehensive economic modelling analysis
Background: Latent tuberculosis infection (LTBI) remains a significant challenge, as there is no gold standard diagnostic test. Current methods used for identifying LTBI are the interferon-γ release assay (IGRA), which is based on a blood test, and the tuberculin skin test (TST), which has low sensitivity. Both these tests are inadequate, primarily because they have limitations with the low bacterial burden characteristic of LTBI. This highlights the need for the development and adoption of more specific and accurate diagnostic tests to effectively identify LTBI. Herein we estimate the cost-effectiveness of the Cy-Tb test as compared with the TST for LTBI diagnosis. Methods: An economic modelling study was conducted from a health system perspective using decision tree analysis, which is most widely used for cost-effectiveness analysis using transition probabilities. Our goal was to estimate the incremental cost and number of TB cases prevented from LTBI using the Cy-Tb diagnostic test along with TB preventive therapy (TPT). Secondary data such as demographic characteristics, treatment outcome, diagnostic test results and cost data for the TST and Cy-Tb tests were collected from the published literature. The incremental cost-effectiveness ratio was calculated for the Cy-Tb test as compared with the TST. The uncertainty in the model was evaluated using one-way sensitivity analysis and probability sensitivity analysis. Results: The study findings indicate that for diagnosing an additional LTBI case with the Cy-Tb test and to prevent a TB case by providing TPT prophylaxis, an additional cost of 18 658 Indian rupees (US${\$}$223.5) is required. The probabilistic sensitivity analysis indicated that using the Cy-Tb test for diagnosing LTBI was cost-effective as compared with TST testing. If the cost of the Cy-Tb test is reduced, it becomes a cost-saving strategy. Conclusions: The Cy-Tb test for diagnosing LTBI is cost-effective at the current price, and price negotiations could further change it into a cost-saving strategy. This finding emphasizes the need for healthcare providers and policymakers to consider implementing the Cy-Tb test to maximize economic benefits. Bulk procurements can also be considered to further reduce costs and increase savings.
- Open Access
- 19 July 2024
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11 (8) , ofae412
Estimating and Explaining the Differences in Health Care Seeking by Symptom Burden Among Persons With Presumptive Tuberculosis: Findings From a Population-Based Tuberculosis Prevalence Survey in a High-Burden Setting in India
Background: There is a lack of research evidence on the quantitative relationship between symptom burden and health care seeking among individuals with presumptive tuberculosis (TB). Methods: Data were derived from a cross-sectional population-based TB survey conducted between February 2021 and July 2022 in 32 districts of India. Eligible and consented participants (age >15 years) underwent TB symptom screening and history elicitation. Fairlie decomposition analysis was used to estimate the net differences in health care seeking due to varied symptom burden—from 1+ burden (>1 symptom) to 4+ burden (>4 symptoms)—and decomposed by observable covariates based on logit models with 95% CIs. Results: Of the 130 932 individuals surveyed, 9540 (7.3%) reported at least 1 recent TB symptom, of whom 2678 (28.1%; 95% CI, 27.1%–28.9%) reportedly sought health care. The net differences in health care seeking among persons with symptom burden 1+ to 4+ ranged from 6.6 percentage points (95% CI, 4.8–8.4) to 7.7 (95% CI, 5.2–10.2) as compared with persons with less symptom burden. The presence of expectoration, fatigue, and loss of appetite largely explained health care seeking (range, 0.9–3.1 percentage points [42.89%–151.9%]). The presence of fever, cough, past TB care seeking, weight loss, and chest pain moderately explained (range, 5.3%–25.3%) health care seeking. Conclusions: Increased symptom burden and symptoms other than the commonly emphasized cough and fever largely explained health care seeking. Orienting TB awareness and risk communications toward symptom burden and illness perceptions could help address population gaps in health care seeking for TB.
- 19 July 2024
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11 (8) , ofae412
Open AccessEstimating and Explaining the Differences in Health Care Seeking by Symptom Burden Among Persons With Presumptive Tuberculosis: Findings From a Population-Based Tuberculosis Prevalence Survey in a High-Burden Setting in India
Background: There is a lack of research evidence on the quantitative relationship between symptom burden and health care seeking among individuals with presumptive tuberculosis (TB). Methods: Data were derived from a cross-sectional population-based TB survey conducted between February 2021 and July 2022 in 32 districts of India. Eligible and consented participants (age >15 years) underwent TB symptom screening and history elicitation. Fairlie decomposition analysis was used to estimate the net differences in health care seeking due to varied symptom burden—from 1+ burden (>1 symptom) to 4+ burden (>4 symptoms)—and decomposed by observable covariates based on logit models with 95% CIs. Results: Of the 130 932 individuals surveyed, 9540 (7.3%) reported at least 1 recent TB symptom, of whom 2678 (28.1%; 95% CI, 27.1%–28.9%) reportedly sought health care. The net differences in health care seeking among persons with symptom burden 1+ to 4+ ranged from 6.6 percentage points (95% CI, 4.8–8.4) to 7.7 (95% CI, 5.2–10.2) as compared with persons with less symptom burden. The presence of expectoration, fatigue, and loss of appetite largely explained health care seeking (range, 0.9–3.1 percentage points [42.89%–151.9%]). The presence of fever, cough, past TB care seeking, weight loss, and chest pain moderately explained (range, 5.3%–25.3%) health care seeking. Conclusions: Increased symptom burden and symptoms other than the commonly emphasized cough and fever largely explained health care seeking. Orienting TB awareness and risk communications toward symptom burden and illness perceptions could help address population gaps in health care seeking for TB.